Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acetylcholine receptor
acetylcholine receptor antibody
adverse drug reaction
algorithm
atypical
autoimmune disease
azathioprine
carcinoma
carcinoma of thyroid
chemotherapy, CNS treatment and complications with
comorbidities
critical care unit
diplopia
efficacy
encephalopathy
epidemiology of neurology
fatigue
gammaglobulin therapy, intravenous
headache
headache, severe
HLA
hypertension
iatrogenic neurologic disorders
immunosuppressive agents
lenvatinib
level of consciousness, decreased
lipoprotein receptor-related protein 4
monoclonal antibodies
MRI, abnormal
muscle weakness
MuSK antibodies
myasthenia gravis
myasthenia gravis, classification
myasthenia gravis, diagnosis
myasthenia gravis, ocular
myasthenia gravis, receptor site in
myasthenia gravis, seronegative
myasthenia gravis, thymectomy in
myasthenia gravis, treatment of
myasthenia gravis, variants
myasthenic crisis
myocarditis
neoplasm, metastatic
neurologic disease, diagnoses of
neuromuscular junction
neuromuscular junction, abnormality of
neuromyelitis optica (Devic's disease)
ophthalmoplegia
plasmapheresis
posterior leukoencephalopathy syndrome
practice guidelines
pregnancy, neurologic complications in
prognosis
ptosis
ptosis, bilateral
quality of life
receptor tyrosine kinase inhibitor
reversible cerebral vasoconstrictive syndromes
review article
rituximab
safety
seizure
steroid
steroid therapy, CNS treatment and complications with
thymectomy
thymic hyperplasia
thymoma
thyroiditis
treatment of neurologic disorder
weakness
weakness, fatiguable
weakness, generalized
white matter disease
Showing articles 550 to 600 of 1841 << Previous Next >>

Autoimmune Encephalopathy
Semin Neurol 31:144-157, Flanagan, E.,et al, 2011

Hashimotos Encephalopathy
Radiol Case Reports 6:445-449, Ramalho, J. & Castillo, M., 2011

Clinical and Genetic Spectrum of Mitochondrial Neurogastrointestinal Encephalomyopathy
Brain 134:3326-3332, Garone, C.,et al, 2011

N-methyl-D-aspartate Receptor Autoimmune Encephalitis Presenting With Opsoclonus-Myoclonus
Arch Neurol 68:1069-1072, Smith, J.H.,et al, 2011

Extended-Release Pramipexole in Advanced Parkinson Disease
Neurol 77:767-774, Schapira, A.H.V.,et al, 2011

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 69:1060-1062, Phan-Ba, R.,et al, 2011

Encephalitis and antibodies to synaptic and neuronal cell surface proteins
Neurol 77:179-189, Lancaster, E.,et al, 2011

Apixaban in Atrial Fibrillation From Bleeding Cows to 21st Century Medicinal Chemistry
Stroke 42:2376-2378, Cucchiara, B.L.,et al, 2011

Posterior cerebral artery susceptibility vessel sign on T2*-weighted gradient echo imaging
Neurol 77:e25, Roh, J.H.,et al, 2011

Progressive Encephalomyelitis with Rigidity and Myoclonus Gycine and NMDA Receptor Antibodies
Neurol 77:439-443,414, Turner, M.R.,et al, 2011

Antidepressant Treatment in Alzheimers Disease
Lancet 378:375-378, Brodaty, H., 2011

Analysis of Relapses in Anti-NMDAR Encephalitis
Neurol 77:996-999, Gabilondo, I.,et al, 2011

Rivaroxaban versus Warfarin in Nonvavular Atrial Fibrillation
NEJM 365:883-891, 952, Patel, M.R.,et al, 2011

The "Million Hearts" Initiative - Preventing Heart Attacks and Strokes
NEJM 365:e27, Frieden, T.R.,et al, 2011

Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis
Arch Neurol 68:1156-1164, Clifford, D.B.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Natalizumab-Associated PML
Neurol 77:1061-1067,1033, Tan, I.L.,et al, 2011

Apixaban versus Warfarin in Patients with Atrial Fibrillation
NEJM 365:981-992,1052, Granger, C.B.,et al, 2011

Clinical Reasoning: A 34-year-old man with recurrent limb weakness
Neurol 77:e68-e72, Karam, C.,et al, 2011

A Randomized, Double-Blind, Placebo Controlled Trial of Simvastatin to Treat Alzheimer Disease
Neurol 77:556-563, Sano, M.,et al, 2011

Autoimmune Limbic Encephalitis with GAD Antibodies
The Neurohospitalist 1:178-181, Finelli, P.F., 2011

Autoimmune encephalitis
BMJ 342:d1918, Irani, S.R.,et all, 2011

A Case of Hashimoto Encephalopathy Clinical Manifestation, Imaging, Pathology, Treatment, and Prognosis
The Neurologist 17:141-143, Zhao, W.,et al, 2011

Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force
Eur J Neurol 18:19-27, Titulaer, M.J.,et al, 2011

Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data
Pharmacol Ther 129:185-194, Terry, K.W.,et al, 2011

Random skin biopsy and bone marrow biopsy for diagnosis of intravascular large B cell lymphoma
Ann Hematol 90:417-421, Matsue, K.,et al, 2011

VGKC antibodies in pediatric encephalitis presenting with status epilepticus
Neurology 76:1252-1255, Suleiman, J.,et al, 2011

New Alternative to Warfarin May Help Reduce Stroke Risk in Patients With AF
JAMA 305:25-26, Mitka,M., 2011

Rhombencephalitis A Series of 97 Patients
Medicine 90:256-261, Moragas, M.,et al, 2011

CSF Complements Serum for Evaluating Paraneoplastic Antibodies and NMO-IgG
Neurol 76:1108-1110, McKeon,A.,et al, 2011

Apixaban in Patients With Atrial Fibrillation
NEJM 364:806-817, Connolly,S.J.,et al, 2011

The Evaluation of Rapidly Progressive Dementia
The Neurologist 17:67-74, Rosenbloom,M.H. &Atri,A., 2011

GABAB Receptor Antibodies in Limbic Encephalitis and Anti-GAD-Associated Neurologic Disorders
Neurol 76:795-800, Boronat,A.,et al, 2011

Effectiveness of Adding Memantine to an Alzheimer Dementia Treatment Regimen Which Already Includes Stable Donepezil Therapy: A Critically Appraised Topic
The Neurologist 17:121-123, Riordan,K.C.,et al, 2011

Rituximab Monotherapy for Patients With Recurrent Primary CNS Lymphoma
Neurol 76:929-930, Batchelor,T.T.,et al, 2011

Rituximab in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Report of 13 Cases and Review of the Literature
JNNP 82:306-308, Benedetti,L.,et al, 2011

Percutaneous Vascular Interventions for Acute Ischemic Stroke
Stroke 42:e31-e32, ORourke,K.,et al, 2011

Spectrum of Paraneoplastic Disease Associated With Lymphoma
Neurol 76:705-710, Briani,C.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy
Arch Neurol 68:186-191, Miravalle,A.,et al, 2011

An Unusual Cause of Symptomatic Tension-Type Headache: Hypertrophic Branchial Myopathy
Neurol 76:488, Desestret,V.,et al, 2011

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
Neurol 76:1697-1704, Vermersch,P.,et al, 2011

The use of rituximab in myasthenia gravis and Lambert--Eaton myasthenic syndrome
JNNP 82:671-673, Maddison, P.,et al, 2011

Use and monitoring of low dose rituximab in myasthenia gravis
JNNP 82:659-663, Blum, S., et al, 2011

Statin Use Following Intracerebral Hemorrhage
Arch Neurol 68:573-579, Westover, M.B.,et al, 2011

Dabigatran Challenges Warfarins Superiority for Stroke Prevention in Atrial Fibrillation
Stroke 41:1307-1309, Schwartz,N.E. &Albers,G.W., 2010

Infectious and Non-Infectious Neurologic Complications in Heart Transplant Recipients
Medicine 89:166-175, Mu�oz,P., et al, 2010

Antibodies to Glutamic Acid Decarboxylase Define a Form of Limbic Encephalitis
Ann Neurol 67:470-478, Malter,M.P., et al, 2010

JC Virus Infection of the Brain
AJNR 31:1564-1576, Bag,A.K.,et al, 2010

Effects of a Central Cholinesterase Inhibitor on Reducing Falls in Parkinson Disease
Neurol 75:1263-1269, Chung,K.A.,et al, 2010

An Effective Immunotherapy Regimen for VGKC Antibody-Positive Limbic Encephalitis
JNNP 81:1167-1169, Wong,S.H.,et al, 2010

Quality of Anticoagulation Control in Atrial Fibrillation
Lancet 376:935-937, Lane,D.A. &Lip,G.Y.H., 2010



Showing articles 550 to 600 of 1841 << Previous Next >>